: The long-term objective of this proposal is to gain insight into mechanisms of cell-mediated immunity and unresponsiveness to intracellular pathogens in humans. Leprosy provides an extraordinary model to investigate these immunoregulatory processes. First, the disease primarily affects skin and is therefore accessible for study, proving a unique opportunity for investigating the nature of the local inflammatory response in human infectious disease. Secondly, the disease represents a spectrum of clinical manifestations that correlate with the pattern of cytokines produced at the site of infection. Patients with the resistant tuberculoid form (T-lep) express type 1 cytokines in lesions; whereas patients with progressive lepromatous form (L-lep) manifest type 2 cytokines in lesions. Our approach has been to study immune responses in lesions at the site of disease activity. Such studies have provided insight that cannot be obtained from the study of the peripheral blood from these patients. We hypothesize that the outcome of the host response to M. leprae is determined by the nature of the innate and adaptive immune response in lesions. We now propose to: 1) elucidate the gene expression profiles associated with resistance versus susceptibility in the human immune response to an intracellular pathogen, 2) determine the role of leukocyte immunoglobulin-like receptor (LIR) family members in contributing to immune unresponsiveness in leprosy; and, 3) elucidate the mechanism by which T-cell recognition of a major microbial antigen contributes to host defense in leprosy. The studies we propose are intended to provide a comprehensive analysis of the immune response in leprosy, comparing host responses in patients that are resistant to infection vs. susceptible to progressive disease. Such studies should provide new insights into mechanisms of immunoregulation in humans, and, we would hope, would provide the ability to predict disease outcome and also lead to the development of new immunomodulatory treatments for a variety of human infectious diseases. These issues are timely, given the rise in emerging infections and the threat of bioterrorist attacks.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI022553-20
Application #
6724468
Study Section
Special Emphasis Panel (ZRG1-TMP (05))
Program Officer
Sizemore, Christine F
Project Start
1991-01-01
Project End
2009-02-28
Budget Start
2004-03-01
Budget End
2005-02-28
Support Year
20
Fiscal Year
2004
Total Cost
$485,456
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Keegan, Caroline; Krutzik, Stephan; Schenk, Mirjam et al. (2018) Mycobacterium tuberculosis Transfer RNA Induces IL-12p70 via Synergistic Activation of Pattern Recognition Receptors within a Cell Network. J Immunol 200:3244-3258
Madigan, Cressida A; Cambier, C J; Kelly-Scumpia, Kindra M et al. (2017) A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy. Cell 170:973-985.e10
Lopez, David; Montoya, Dennis; Ambrose, Michael et al. (2017) SaVanT: a web-based tool for the sample-level visualization of molecular signatures in gene expression profiles. BMC Genomics 18:824
Scumpia, Philip O; Botten, Giovanni A; Norman, Joshua S et al. (2017) Opposing roles of Toll-like receptor and cytosolic DNA-STING signaling pathways for Staphylococcus aureus cutaneous host defense. PLoS Pathog 13:e1006496
Realegeno, Susan; Kelly-Scumpia, Kindra M; Dang, Angeline Tilly et al. (2016) S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages. PLoS Pathog 12:e1005705
Kibbie, Jon; Teles, Rosane M B; Wang, Zhiming et al. (2016) Jagged1 Instructs Macrophage Differentiation in Leprosy. PLoS Pathog 12:e1005808
Schenk, Mirjam; Mahapatra, Sebabrata; Le, Phuonganh et al. (2016) Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae. Infect Immun 84:2429-38
Rotcheewaphan, Suwatchareeporn; Belisle, John T; Webb, Kristofor J et al. (2016) Diguanylate cyclase activity of the Mycobacterium leprae T cell antigen ML1419c. Microbiology 162:1651-1661
Inkeles, Megan S; Teles, Rosane M B; Pouldar, Delila et al. (2016) Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight 1:e88843
Busch, Martin; Herzmann, Christian; Kallert, Stephanie et al. (2016) Lipoarabinomannan-Responsive Polycytotoxic T Cells Are Associated with Protection in Human Tuberculosis. Am J Respir Crit Care Med 194:345-55

Showing the most recent 10 out of 42 publications